Replies to post #163644 on Biotech Values

[dav1234]

That's a blurb quoting Adam F..not me

$AMRN Vascepa Rx growth (month over month) since launch: 125%, 70%, 31%, 14%

— Adam Feuerstein ✡️ (@adamfeuerstein) July 8, 2013